HRT Financial LLC acquired a new position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 4,743 shares of the medical instruments supplier’s stock, valued at approximately $207,000.
Several other large investors also recently bought and sold shares of the company. BlackRock Inc. lifted its stake in shares of DENTSPLY SIRONA by 0.7% during the first quarter. BlackRock Inc. now owns 14,269,268 shares of the medical instruments supplier’s stock worth $717,889,000 after buying an additional 99,455 shares during the period. Veritas Asset Management LLP lifted its stake in shares of DENTSPLY SIRONA by 19.9% during the second quarter. Veritas Asset Management LLP now owns 10,092,601 shares of the medical instruments supplier’s stock worth $441,753,000 after buying an additional 1,674,946 shares during the period. Bank of America Corp DE lifted its stake in shares of DENTSPLY SIRONA by 18.2% during the second quarter. Bank of America Corp DE now owns 3,112,821 shares of the medical instruments supplier’s stock worth $136,248,000 after buying an additional 479,365 shares during the period. Orbimed Advisors LLC lifted its stake in shares of DENTSPLY SIRONA by 963.8% during the second quarter. Orbimed Advisors LLC now owns 2,393,500 shares of the medical instruments supplier’s stock worth $104,763,000 after buying an additional 2,168,500 shares during the period. Finally, Champlain Investment Partners LLC lifted its stake in shares of DENTSPLY SIRONA by 23.7% during the first quarter. Champlain Investment Partners LLC now owns 2,218,395 shares of the medical instruments supplier’s stock worth $111,607,000 after buying an additional 424,910 shares during the period. Institutional investors and hedge funds own 97.65% of the company’s stock.
Shares of DENTSPLY SIRONA stock opened at $38.42 on Monday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.69 and a quick ratio of 1.10. DENTSPLY SIRONA Inc has a 1 year low of $37.46 and a 1 year high of $68.98. The firm has a market cap of $8.62 billion, a P/E ratio of 14.44, a price-to-earnings-growth ratio of 2.24 and a beta of 1.20.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.01. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. The company had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the previous year, the company earned $0.65 earnings per share. equities analysts anticipate that DENTSPLY SIRONA Inc will post 2.08 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 12th. Shareholders of record on Friday, September 28th will be issued a $0.0875 dividend. The ex-dividend date is Thursday, September 27th. This represents a $0.35 dividend on an annualized basis and a yield of 0.91%. DENTSPLY SIRONA’s payout ratio is 13.16%.
Several research firms have recently commented on XRAY. BidaskClub upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Friday, July 6th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research note on Wednesday, June 6th. Barclays lowered their price objective on shares of DENTSPLY SIRONA from $55.00 to $41.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 8th. HC Wainwright set a $40.00 target price on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a report on Friday, August 31st. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $54.00 to $40.00 in a report on Wednesday, August 8th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $52.18.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: What are the most popular ETFs
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.